Target Ovarian Cancer

Target Ovarian Cancer launches new videos and guide with the PIF TICK

PIF member's resources provide trusted information to help women and their families make decisions.

An updated guide and new animated videos about genetic testing for ovarian cancer have been launched by Target Ovarian Cancer. The resources include easy-to-understand information about who is eligible for genetic testing under the new NICE guidelines and the current National Genomic Test Directory. 

The PIF member says the aim of the guide is to increase understanding of what genetic testing is, which genes are tested and who can access testing as well as provide information about treatment options for ovarian cancer if someone has a gene variant. The information can help someone with a diagnosis of ovarian cancer to make decisions about whether to have genetic testing and how to talk to their families about the possibility of passing down a gene variant.  

The guide covers:

  • What genetic variants are.
  • Which gene variants can be passed on through families.
  • Whether your family members are at risk of developing cancer.
  • What genetic tests your treatment team may offer you.
  • How having a genetic variant could change your treatment options.
  • Ways to manage your risk of developing other cancers if you have a genetic variant.

Co-produced and in line with the PIF TICK

The guide was co-produced with the help of health professionals and experts in ovarian cancer and genetics. It also includes thoughts from those who have a gene variant themselves. The guide and videos were produced in line with the PIF TICK criteria, using health information which is evidence-based, up to date, and easy to use and understand. The animated videos were created to complement the guide and show clear information about the process of getting tested for inherited gene variants and homologous recombination deficiency (HRD).

'Guide will be of immense benefit'

Prof Ranjit Manchanda, Professor of Gynaecological Oncology and Consultant Gynaecological Oncologist at Wolfson Institute of Population Health, Queen Mary University of London and Barts Health NHS Trust, helped to review the guide. They said: “Target Ovarian Cancer’s updated genetic testing guide covers all the important issues for women with ovarian cancer and their families. It will be of immense benefit to our patients and their families. This guide provides trusted information to help women and their families make decisions that are right for them.”

Find the genetic testing resources on Target Ovarian Cancer’s website here.

Download the guide from the Target Ovarian Cancer website here.